Bongiovanni, A.; Maiorano, B.A.; Azzali, I.; Liverani, C.; Bocchini, M.; Fausti, V.; Di Menna, G.; Grassi, I.; Sansovini, M.; Riva, N.;
et al. Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Pharmaceuticals 2021, 14, 476.
https://doi.org/10.3390/ph14050476
AMA Style
Bongiovanni A, Maiorano BA, Azzali I, Liverani C, Bocchini M, Fausti V, Di Menna G, Grassi I, Sansovini M, Riva N,
et al. Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Pharmaceuticals. 2021; 14(5):476.
https://doi.org/10.3390/ph14050476
Chicago/Turabian Style
Bongiovanni, Alberto, Brigida Anna Maiorano, Irene Azzali, Chiara Liverani, Martine Bocchini, Valentina Fausti, Giandomenico Di Menna, Ilaria Grassi, Maddalena Sansovini, Nada Riva,
and et al. 2021. "Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis" Pharmaceuticals 14, no. 5: 476.
https://doi.org/10.3390/ph14050476
APA Style
Bongiovanni, A., Maiorano, B. A., Azzali, I., Liverani, C., Bocchini, M., Fausti, V., Di Menna, G., Grassi, I., Sansovini, M., Riva, N., & Ibrahim, T.
(2021). Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Pharmaceuticals, 14(5), 476.
https://doi.org/10.3390/ph14050476